PRACTICES

Competition in the healthcare and life sciences industries is intensifying on a global scale, making it challenging even for major players to pursue R&D, manufacturing and marketing on their own. Pharmaceutical, medical device and biotechnology companies have sought our advice for their licensing deals, joint research and development projects, acquisitions, capital tie-ups and joint ventures.

Regulatory compliance and contractual and IP-related disputes also present major business risks. We have advised numerous healthcare and life sciences companies on strategies to mitigate and manage regulatory compliance risks and worked with them to resolve potential and actual disputes.